Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 4.6.2024Medreg s.r.o. (MRG-2)4243EFlaxios (tbl flm 180x500 mg (blis.PVC/Al))29.5.2024U
 4.6.2024Dr. Max Pharma s.r.o. (DAX)1230CAcetylcystein Dr.Max 600 mg (tbl eff 20x600 mg (strip laminát/Al/papier))22.5.2024U
 4.6.2024Bayer AG (BAY)8504DVITRAKVI 20 mg/ml perorálny roztok (sol por 2x50 ml (fľ.skl.jantár.))4.6.2024O
 4.6.2024Pfizer Europe MA EEIG (PFI-BE-3)05886GENOTROPIN 12 mg (plv iol 1x12 mg (náplň inj.skl.dvojkom.+pero GoQuick))5.6.2024O
 4.6.2024Zentiva, k.s. (ZNT-1)0860EJamesi 50 mg/850 mg (tbl flm 196x50 mg/850 mg (blis.PVC/PVDC/Al))4.6.2024R
 4.6.2024Zentiva, k.s. (ZNT-1)2115DAcidum folicum Léčiva (tbl obd 45x10 mg (blis. PVC/Al))4.6.2024R
 4.6.2024Zentiva, k.s. (ZNT-1)7164DConaret 2,5 mg tablety (tbl 30x2,5 mg (blis.PVC/PVdC//Al))4.6.2024R
 3.6.2024B.Braun Melsungen AG (BME)0018AParacetamol B. Braun 10 mg/ml (sol inf 10x50 ml/500 mg (fľ.LDPE))3.6.2024O
 3.6.2024ARDEZ Pharma, spol. s r.o. (ARZ)5050DTadard 5 mg (tbl flm 28x5 mg (blis.PVC/PVDC/Al))6.6.2024R
 3.6.2024TS Pharma s.r.o. (TPH-1)41784MeniSerc 24 (tbl 50x24 mg (blis.PVC/PVDC/Al))3.6.2024O
 3.6.2024Viatris Limited (VIM)5800CSeizpat 100 mg (tbl flm 56x100 mg (blis.PVC/PVDC/Al))3.6.2024O
 3.6.2024Viatris Limited (VIM)2264EVixargio 20 mg filmom obalené tablety (tbl flm 28x20 mg (blis.PVC/PVDC/Al))4.6.2024O
 3.6.2024Viatris Limited (VIM)2266EVixargio 20 mg filmom obalené tablety (tbl flm 98x20 mg (blis.PVC/PVDC/Al))4.6.2024O
 3.6.2024Viatris Healthcare Limited (VIM-1)6610BCholib 145 mg/20 mg filmom obalené tablety (tbl flm 90x145 mg/20 mg (blis.Al/Al))7.6.2024O
 2.6.2024STADA Arzneimittel AG (STD)4856EDezmopresín Stada 60 mikrogramov sublingválne tablety (tbl slg 100x60 µg (fľ.HDPE))31.5.2024U

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To